Cargando…

Shen Shuai IIRecipe attenuates renal injury and fibrosis in chronic kidney disease by regulating NLRP3 inflammasome and Sirt1/Smad3 deacetylation pathway

BACKGROUND: Excessive activation of NLRP3 inflammasome and down-regulation of Sirt1/Smad3 deacetylation pathway play a significant role in the evolution of renal fibrosis. In China, it has been well known that Chinese herbal medicine is markedly effective in treating chronic kidney disease (CKD). Sh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Meng, Yang, Liuyi, Yang, Jing, Wang, Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530021/ https://www.ncbi.nlm.nih.gov/pubmed/31118021 http://dx.doi.org/10.1186/s12906-019-2524-6

Ejemplares similares

Shen Shuai II Recipe Attenuates Renal Interstitial Fibrosis by Improving Hypoxia via the IL-1β/c-Myc Pathway
por: Yang, Liuyi, et al.
Publicado: (2021)

SIRT2 alleviated renal fibrosis by deacetylating SMAD2 and SMAD3 in renal tubular epithelial cells
por: Yang, Shu, et al.
Publicado: (2023)

ShenShuai II Recipe Attenuates Apoptosis and Renal Fibrosis in Chronic Kidney Disease by Increasing Renal Blood Flow and Improving Oxygen Consumption
por: Wang, Meng, et al.
Publicado: (2018)

Inhibitory Potential of Shen-Shuai-Ling Formulation on Renal Interstitial Fibrosis via Upregulation of PLZF
por: Song, Na, et al.
Publicado: (2022)

Shen-Shuai-Ling Formulation Attenuates Renal Interstitial Fibrosis in Chronic Kidney Disease by Regulating SHH-Gli1 Signaling Pathway
por: Li, Ying, et al.
Publicado: (2022)

SIRT6 Protects Against Liver Fibrosis by Deacetylation and Suppression of SMAD3 in Hepatic Stellate Cells
por: Zhong, Xiaolin, et al.
Publicado: (2020)

Shen Shuai II Recipe Attenuates Apoptosis in 5/6 Renal Ablation/Infarction Rats by Inhibiting p53 and the Mitochondrial Pathway of Apoptosis
por: Wang, Meng, et al.
Publicado: (2020)

SIRT3-mediated deacetylation of NLRC4 promotes inflammasome activation
por: Guan, Chenyang, et al.
Publicado: (2021)

Protective effects and regulatory mechanisms of Shen-shuai-yi recipe on renal fibrosis in unilateral ureteral obstruction-induced mice
por: Lin, Ping-lan, et al.
Publicado: (2023)

Modulation of the Gut Microbiota by Shen-Yan-Fang-Shuai Formula Improves Obesity Induced by High-Fat Diets
por: Wang, Zhen, et al.
Publicado: (2020)

Resveratrol ameliorates myocardial fibrosis by regulating Sirt1/Smad3 deacetylation pathway in rat model with dilated cardiomyopathy
por: Chen, Qingquan, et al.
Publicado: (2022)

Shen-Shuai-Ning granule decreased serum concentrations of indoxyl sulphate in uremic patients undergoing peritoneal dialysis
por: Chen, Xujiao, et al.
Publicado: (2018)

BuShenKangShuai Tablet Alleviates Hepatic Steatosis via Improving Liver Adiponectin Resistance in ApoE(−/−) Mice
por: Pang, Shu-chao, et al.
Publicado: (2019)

The Role of the NLRP3 Inflammasome in Fibrosis
por: Artlett, Carol M
Publicado: (2012)

Renoprotective Effect of the Shen-Yan-Fang-Shuai Formula by Inhibiting TNF-α/NF-κB Signaling Pathway in Diabetic Rats
por: Lv, Jie, et al.
Publicado: (2017)

Gemigliptin Attenuates Renal Fibrosis Through Down-Regulation of the NLRP3 Inflammasome
por: Seo, Jung Beom, et al.
Publicado: (2019)

Dual Role of Triptolide in Interrupting the NLRP3 Inflammasome Pathway to Attenuate Cardiac Fibrosis
por: Pan, Xi-Chun, et al.
Publicado: (2019)

Sirt6 Alleviated Liver Fibrosis by Deacetylating Conserved Lysine 54 on Smad2 in Hepatic Stellate Cells
por: Zhang, Jinhang, et al.
Publicado: (2020)

Sinensetin Attenuated Macrophagic NLRP3 Inflammasomes Formation via SIRT1-NRF2 Signaling
por: Lin, Lin, et al.
Publicado: (2023)

The Role of Autophagy and NLRP3 Inflammasome in Liver Fibrosis
por: Tao, Ye, et al.
Publicado: (2020)

Activating SIRT1 deacetylates NF-κB p65 to alleviate liver inflammation and fibrosis via inhibiting NLRP3 pathway in macrophages
por: He, Shuli, et al.
Publicado: (2023)

Mouse SIRT3 Attenuates Hypertrophy-Related Lipid Accumulation in the Heart through the Deacetylation of LCAD
por: Chen, Tongshuai, et al.
Publicado: (2015)

Effect and Regulation of the NLRP3 Inflammasome During Renal Fibrosis
por: Zhang, Hong, et al.
Publicado: (2020)

Integrating network pharmacology and experimental validation to decipher the mechanism of the Chinese herbal prescription modified Shen-Yan-Fang-Shuai formula in treating diabetic nephropathy
por: Yu, Borui, et al.
Publicado: (2023)

Natural Products that Target the NLRP3 Inflammasome to Treat Fibrosis
por: Ding, Nan, et al.
Publicado: (2020)

The Mechanism and Regulation of the NLRP3 Inflammasome during Fibrosis
por: Artlett, Carol M.
Publicado: (2022)

Inhibition of FABP4 attenuates cardiac fibrosis through inhibition of NLRP3 inflammasome activation
por: Zhu, Xi, et al.
Publicado: (2022)

Correction: Mouse SIRT3 Attenuates Hypertrophy-Related Lipid Accumulation in the Heart through the Deacetylation of LCAD
por: Chen, Tongshuai, et al.
Publicado: (2016)

Age‐dependent loss of hepatic SIRT1 enhances NLRP3 inflammasome signaling and impairs capacity for liver fibrosis resolution
por: Adjei‐Mosi, Jennifer, et al.
Publicado: (2023)

Role of SIRT1 in Hepatic Encephalopathy: In Vivo and In Vitro Studies Focusing on the NLRP3 Inflammasome
por: Jiao, Fangzhou, et al.
Publicado: (2021)

SIRT3-mediated inhibition of FOS through histone H3 deacetylation prevents cardiac fibrosis and inflammation
por: Palomer, Xavier, et al.
Publicado: (2020)

The NLRP3 Inflammasome as a Novel Therapeutic Target for Cardiac Fibrosis
por: Fan, Jiwen, et al.
Publicado: (2022)

Annatto Tocotrienol Attenuates NLRP3 Inflammasome Activation in Macrophages
por: Buckner, Teresa, et al.
Publicado: (2017)

Saffron extract attenuates neuroinflammation in rmTBI mouse model by suppressing NLRP3 inflammasome activation via SIRT1
por: Shaheen, Mariam J., et al.
Publicado: (2021)

SIRT3 Regulates Clearance of Apoptotic Cardiomyocytes by Deacetylating Frataxin
por: Gao, Jing, et al.
Publicado: (2023)

NLRP3 inflammasome in endothelial dysfunction
por: Bai, Baochen, et al.
Publicado: (2020)

Shikonin Ameliorates LPS-Induced Cardiac Dysfunction by SIRT1-Dependent Inhibition of NLRP3 Inflammasome
por: Guo, Tao, et al.
Publicado: (2020)

Research Progress of Mitochondrial Mechanism in NLRP3 Inflammasome Activation and Exercise Regulation of NLRP3 Inflammasome
por: Zhang, Tan, et al.
Publicado: (2021)

The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3
por: Song, Hui, et al.
Publicado: (2016)

Autophagy attenuates tubulointerstital fibrosis through regulating transforming growth factor-β and NLRP3 inflammasome signaling pathway
por: Nam, Sun Ah, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0ptislvepi6p2ie8ismnk7ah3i